D. E. Shaw & Co. Inc. Purchases 453,093 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

D. E. Shaw & Co. Inc. raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 502.0% during the fourth quarter, Holdings Channel reports. The fund owned 543,346 shares of the company’s stock after buying an additional 453,093 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Acadia Healthcare were worth $21,544,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Lindbrook Capital LLC boosted its stake in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. lifted its stake in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC boosted its position in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the period. Finally, Quadrant Capital Group LLC grew its stake in shares of Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after buying an additional 933 shares during the last quarter.

Acadia Healthcare Trading Down 1.4%

NASDAQ:ACHC opened at $23.87 on Monday. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $26.57 and a 200-day moving average price of $36.32. The stock has a market cap of $2.20 billion, a price-to-earnings ratio of 7.83, a P/E/G ratio of 1.46 and a beta of 1.01.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Mizuho dropped their target price on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a report on Tuesday, March 25th. KeyCorp lowered their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. Bank of America cut their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Royal Bank of Canada lowered their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Finally, Guggenheim initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $50.39.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.